Location History:
- Suita, JP (1981 - 1984)
- Osaka, JP (1985)
Company Filing History:
Years Active: 1981-1985
Title: Kumao Toyoshima: Innovator in Carcinostatic Agents
Introduction
Kumao Toyoshima is a notable inventor based in Suita, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of carcinostatic agents. With a total of 3 patents to his name, Toyoshima's work has the potential to impact cancer treatment and viral detection.
Latest Patents
Toyoshima's latest patents include a polypeptide carcinostatic agent, which contains a polypeptide of a specific formula. This agent is designed to combat cancer by utilizing novel polypeptides that serve as carcinostatic agents and as tools for the detection and determination of viruses. The polypeptides he developed consist of forty-five amino acid residues and feature a unique tetracyclic structure, bridged by four disulfide bonds between specific cysteine molecular pairs.
Career Highlights
Throughout his career, Kumao Toyoshima has been associated with Suntory Limited, where he has been able to apply his innovative ideas in a collaborative environment. His research has focused on the intersection of biotechnology and medicine, leading to advancements in cancer treatment methodologies.
Collaborations
Some of Toyoshima's notable coworkers include Akira Hakura and Toshihiro Nakanishi. Their collaborative efforts have contributed to the success of various projects and innovations within their field.
Conclusion
Kumao Toyoshima's work in developing polypeptide carcinostatic agents showcases his dedication to advancing medical science. His contributions are paving the way for new treatments in oncology and viral detection, highlighting the importance of innovation in healthcare.